SCHEMBL19728162

SCHEMBL19728162

CC(C)CCCNCC1CC1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SAT1 P21673 1/20 0.55
GNAI3 P08754 2/20 0.42
GNAO1 P09471 2/20 0.42
GNAI1 P63096 2/20 0.42
ALDH1A1 P00352 2/20 0.34
CYP1A2 P05177 1/20 0.34
CYP3A4 P08684 1/20 0.34
CYP2C9 P11712 1/20 0.34
CYP2C19 P33261 1/20 0.34
GAA P10253 2/20 0.33
CNR1 P21554 1/20 0.33
CNR2 P34972 1/20 0.33
RAB9A P51151 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
MEN1 O00255 1/20 0.33
KMT2A Q03164 1/20 0.33
LMNA P02545 1/20 0.32
HDAC3 O15379 1/20 0.32
HDAC4 P56524 1/20 0.32
HDAC1 Q13547 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16691371 0.94 SAT1 (0.53) SAT1GNAI3GNAO1GNAI1ALDH1A1
SCHEMBL16691373 0.92 SAT1 (0.52) SAT1GNAI3GNAO1GNAI1ALDH1A1
SCHEMBL19728164 0.90 SAT1 (0.46) SAT1GNAI3GNAO1GNAI1ALDH1A1
SCHEMBL23059867 0.90 SAT1 (0.46) SAT1GNAI3GNAO1GNAI1ALDH1A1
SCHEMBL24845617 0.88 SAT1 (0.49) SAT1GNAI3GNAO1GNAI1CYP1A2
SCHEMBL4670470 0.86 SAT1 (0.48) SAT1GNAI3GNAO1GNAI1ALDH1A1
SCHEMBL19734413 0.79 SAT1 (0.42) SAT1GNAI3GNAO1GNAI1ALDH1A1
SCHEMBL21743264 0.78 ALDH1A1 (0.46) SAT1GNAI3GNAO1GNAI1ALDH1A1
SCHEMBL19728163 0.77 ALDH1A1 (0.44) SAT1ALDH1A1CYP1A2CYP3A4CYP2C9
SCHEMBL29827347 0.77 SAT1 (0.53) SAT1GNAI3GNAO1GNAI1HDAC3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170362217-A1 Substituted Piperidine Compounds Epizyme, Inc. (US) 2017-12-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170362217-A1 Substituted Piperidine Compounds SMYD3, SMYD2, SNRPD3 SAT1 597/4885GNAI3 405/4885GNAO1 2302/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.